<DOC>
	<DOCNO>NCT02255188</DOCNO>
	<brief_summary>The purpose study determine whether Vascular prosthesis manufacture Electrospinning safe respect development thrombosis .</brief_summary>
	<brief_title>Experimental Study Vascular Prosthesis Manufactured Electrospinning</brief_title>
	<detailed_description>To test influence prosthesis hemostasis blood pump vascular prosthesis control silicone tube ( identical inner diameter 1,7 mm ) 20 minute linear velocity 10 cm/sec ( correspond 18 ml/min ) . The tested prosthesis ( control tube ) instal two syrinx blood installed UTPS-1 instrument provide synchronical movement piston syrinx . Installing UTPS-1 design manufacture Institute Chemical Biology Fundamental Medicine , Siberian Branch Russian Academy Sciences consist mechanical pusher , equip clamp syrinx piston , stepper motor , electronic control unit power supply . UTPS-1 polypropylene non-pyrogenic syrinx fill blood without bulbs air provide absence contact air , pyrogens minimize lysis blood cell . UTPS-1 analogue , require licensure , metrological control obtain permit . After pump blood separate plasma cell fraction accord standard laboratory method . Primary blood ( treatment ) , blood pump silicon tube ( control ) , vascular prosthesis test hemostatic parameter . Notification basic additional parameter study , evaluate study : 1 . The initial parameter blood hemostasis evaluate ( Platelet count ; Platelet aggregation ; Prothrombin time , International Normalised Ratio [ INR ] , activate partial thromboplastin time ( aPTT ) , prothrombin Quick , thrombin time , soluble fibrin monomer complex ( SFMC ) , free hemoglobin P- selectin concentration ) . 2 . To evaluate influence prosthesis circulate blood hemostasis characteristic wiil evaluate blood 20 min circulation prosthesis silicon tube ( Platelet count ; Platelet aggregation ; Prothrombin time , International Normalised Ratio [ INR ] , activate partial thromboplastin time ( aPTT ) , prothrombin Quick , thrombin time , soluble fibrin monomer complex ( SFMC ) , measurement free hemoglobin , P- selectin ) . 3 . Microscopy : study adhesion blood cell surface prosthesis Description Design Research : prospective ( marked section Detailed Description ) Monocentred research Defined indicator prosthesis 1. hemostasis characteristic list hereinabove untreated blood ( control ) 2 hemostasis characteristic list hereinabove blood 20 min circulation silicone tube ( control ) 3 hemostasis characteristic list hereinabove blood 20 min circulation After interaction experimental vascular prosthesis Will study 4 type vascular prosthesis make electrospinning - polycaprolactone ; - polycaprolactone / gelatin/poorly permeable layer ; - polylactide-co-glycolide / polycaprolactone / gelatin/poorly permeable layer ; - nylon 6</detailed_description>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Male female age 18 50 year date inform consent signing ; Patients without atherosclerosis Patients without blood pathology Patient sign inform consent . Early postoperative period . Concomitant disease atherosclerosis , blood pathology , venous thrombosis , malignancy , terminal cancer , infectious inflammatory disease time study . Patients implantation cardioverterdefibrillator ; prior prosthetic heart valves implant , lead mechanical damage blood cell . Receiving anticoagulant , antiplatelet , antibacterial drug , NSAIDs . Myocardial infarction le 3 month ago . Irreversible failure major organ expect survival time less 1 year Pregnancy , lactation . Age 50 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Haemostas , prosthesis</keyword>
</DOC>